{
    "organizations": [],
    "uuid": "6130f2c28fe9f5a9aadcf3f3aa4eb6fb27f3c4c7",
    "author": "",
    "url": "https://www.reuters.com/article/brief-rigel-pharmaceuticals-nda-for-tava/brief-rigel-pharmaceuticals-nda-for-tavalisse-approved-by-fda-idUSFWN1RU19A",
    "ord_in_thread": 0,
    "title": "BRIEF-Rigel Pharmaceuticals NDA For Tavalisse Approved By FDA",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 17, 2018 / 6:03 PM / Updated 21 minutes ago BRIEF-Rigel Pharmaceuticals NDA For Tavalisse Approved By FDA Reuters Staff \nApril 17 (Reuters) - U.S. Food And Drug Administration: \n* RIGEL PHARMACEUTICALS NDA FOR TAVALISSE APPROVED BY FDA Source text: ( bit.ly/2HGn96a ) Further company coverage:",
    "published": "2018-04-17T21:02:00.000+03:00",
    "crawled": "2018-04-17T21:12:44.029+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "pm",
        "updated",
        "minute",
        "ago",
        "pharmaceutical",
        "nda",
        "tavalisse",
        "approved",
        "fda",
        "reuters",
        "staff",
        "april",
        "reuters",
        "food",
        "drug",
        "administration",
        "rigel",
        "pharmaceutical",
        "nda",
        "tavalisse",
        "approved",
        "fda",
        "source",
        "text",
        "company",
        "coverage"
    ]
}